The Biopharmaceutical Classification System (BCS) categorizes drug substances based on their solubility, permeability, and dissolution rate to predict in vivo pharmacokinetics of oral drug products. It aids in drug discovery, biowaiver considerations, and regulatory processes by allowing for the replacement of certain bioequivalence studies with in vitro dissolution tests. The system classifies drugs into four classes, each with specific characteristics regarding absorption and therapeutic action.